Horie and Sato (IMAGE) Washington University School of Medicine Caption Kanta Horie, PhD, (left) and Chihiro Sato, PhD, discuss data in the Tracy Family SILQ Center at Washington University School of Medicine in St. Louis. Sato and Horie led a team that discovered a biomarker for a rare, deadly brain disease known as corticobasal degeneration (CBD). The biomarker could accelerate efforts to develop treatments for CBD. Credit Matt Miller/Washington University Usage Restrictions This image is to be used in accordance with the mission, policies and guidelines of Washington University in St. Louis. Visit https://wustl.edu/about/compliance-policies/media-policies/multimedia-use/ for more information. License Original content Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.